The isoflavone intake and ecole production ability as a prostate cancer risk ; double blind placebo study - The isoflavone intake and ecole production ability as a prostate cancer risk

Graduate School of Comprehensive Human Sciences, University of Tsukuba0 个研究点目标入组 280 人开始时间: 2006年7月10日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. History of a prostate cancer 2. High grade PIN in the prostate needle biopsy 3. Past history of surgery of the prostate(transurethral resection, balloon dilation, hyperthermia, stenting et al.) 4. Past history of malignant disease within 5 years other than basal cell carcinoma or squamous cell carcinoma of the skin. 5. The myocardial infarction, coronary artery bypass,unstable angina, arrhythmia, congestive heart failure, cerebral ischemia, uncontrolled diabetes or controlled peptic ulcer. 6. Abnormalities of liver function; more than double level of AST, ALT or ALP, time and a half level of bilirubin. 7. Abnormalities of renal function; more than time and a half level of creatinin. 8. Combined use or use within 12 months of the following drugs; 5 alpha-reductase inhibitor, steroid hormone, anti-androgens (fultamide, bicalutamide, chlormadinone acetate, estrogen, progesterone).anti-androgen action.

发起方

Graduate School of Comprehensive Human Sciences, University of Tsukuba